Page last updated: 2024-08-21

medroxyprogesterone and Weight Gain

medroxyprogesterone has been researched along with Weight Gain in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's0 (0.00)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Dias-da-Silva, MR; do Nascimento Verreschi, IT; Mathez, ALG; Monteagudo, PT1
Afzal, M; Chaudhri, R; Rizvi, F1
Bonny, AE; Cromer, BA; Debanne, SM; Harvey, R; Secic, M; Ziegler, J1
Begier, EA; Kim, C; Kwok, YS; Seidel, KW1
Cooper, L; Hart, BL1
Dupuis, M; Gimotty, P; Russo, IH; Russo, J1
Inaii, H; Koyama, H; Noguchi, S; Yamamoto, H1

Trials

2 trial(s) available for medroxyprogesterone and Weight Gain

ArticleYear
Body weight and bleeding pattern changes in women using DMPA-SC.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2009, Volume: 19, Issue:10

    Topics: Adult; Amenorrhea; Body Mass Index; Body Weight; Contraceptives, Oral, Synthetic; Female; Humans; Injections, Subcutaneous; Medroxyprogesterone; Multivariate Analysis; Risk Factors; Severity of Illness Index; Sex Factors; Time Factors; Weight Gain

2009
Comparison of diazepam with progestin for effectiveness in suppression of urine spraying behavior in cats.
    Journal of the American Veterinary Medical Association, 1992, Mar-15, Volume: 200, Issue:6

    Topics: Animals; Appetite; Ataxia; Behavior, Animal; Cat Diseases; Cats; Diazepam; Female; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Progestins; Recurrence; Sleep; Urination Disorders; Weight Gain

1992

Other Studies

5 other study(ies) available for medroxyprogesterone and Weight Gain

ArticleYear
Levonorgestrel correlates with less weight gain than other progestins during hormonal replacement therapy in Turner Syndrome patients.
    Scientific reports, 2020, 05-19, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Body Mass Index; Contraceptive Agents, Hormonal; Cross-Sectional Studies; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Medroxyprogesterone; Progestins; Retrospective Studies; Treatment Outcome; Turner Syndrome; Weight Gain; Young Adult

2020
Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method.
    Archives of pediatrics & adolescent medicine, 2006, Volume: 160, Issue:1

    Topics: Adolescent; Ambulatory Care Facilities; Analysis of Variance; Body Mass Index; Case-Control Studies; Child; Contraceptives, Oral; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone; Obesity; Prospective Studies; United States; Urban Health Services; Weight Gain

2006
Diabetes and depot medroxyprogesterone contraception in Navajo women.
    Archives of internal medicine, 2001, Jul-23, Volume: 161, Issue:14

    Topics: Adult; Case-Control Studies; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Diabetes Mellitus; Female; Humans; Indians, North American; Insulin Resistance; Medical Records; Medroxyprogesterone; Middle Aged; Odds Ratio; Progesterone Congeners; Retrospective Studies; Risk Factors; Time Factors; United States; United States Indian Health Service; Weight Gain

2001
Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis.
    British journal of cancer, 1989, Volume: 59, Issue:2

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Aging; Animals; Drug Administration Schedule; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Rats; Rats, Inbred Strains; Weight Gain

1989
[Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Recurrence; Remission Induction; Soft Tissue Neoplasms; Tamoxifen; Weight Gain

1989